Showing results (161-170 of 178) with videos related to
Sort By:
Pageof 18
Radiation (Multidisciplinary Digital Publishing Institute)|April 23, 2026
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint InhibitorsCynthia Lilieholm, Jen Zaborek, Ohyun Kwon, et al.Plos One|June 30, 2018
Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical featuresKee Hong Park, Patrick Waters, Mark Woodhall, et al.Plos One|March 9, 2018
Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical featuresKee Hong Park, Patrick Waters, Mark Woodhall, et al.Nature Communications|July 29, 2021
Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasisThirupura S Shankar, Dinesh K A Ramadurai, Kira Steinhorst, et al.Journal of the Neurological Sciences|September 7, 2024
Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disordersHye Lim Lee, Jin Myoung Seok, Soon-Young Hwang, et al.Radiation Research|March 25, 2026
Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcsCaroline P Kerr, Won Jong Jin, Alejandro J Oñate, et al.Multiple Sclerosis and Related Disorders|August 12, 2019
Changing patterns of multiple sclerosis in Korea: Toward a more baseline MRI lesions and intrathecal humoral immune responsesHyun-June Shin, Jae-Won Hyun, Su-Hyun Kim, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
Priming versus propagating: distinct immune effects of an alpha- versus beta-particle emitting radiopharmaceutical when combined with immune checkpoint inhibitionCaroline P Kerr, Won Jong Jin, Peng Liu, et al.Nature Communications|January 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in miceCaroline P Kerr, Won Jong Jin, Peng Liu, et al.Biorxiv : the Preprint Server for Biology|February 12, 2026
A MET-Targeted Variable New Antigen Receptor (VNAR) Theranostic for Non-Small Cell Lung CancerRachel L Minne, Jayden L West, Natalie Y Luo, et al.Pageof 18